Proteomics identification of PGAM1 as a potential therapeutic target for urothelial bladder cancer
Authors:
- 1 January 2016
- journal article
- research article
- Published by Elsevier in Journal of Proteomics
- Vol. 132, 85-92
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Comprehensive molecular characterization of urothelial bladder carcinomaNature, 2014
- Cancer statistics, 2014CA: A Cancer Journal for Clinicians, 2014
- Phosphoglycerate Mutase 1 Coordinates Glycolysis and Biosynthesis to Promote Tumor GrowthCancer Cell, 2012
- Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell ProliferationAnnual Review of Cell and Developmental Biology, 2011
- Comparative Proteomic Approach Identifies Pkm2 and Cofilin-1 as Potential Diagnostic, Prognostic and Therapeutic Targets for Pulmonary AdenocarcinomaPLOS ONE, 2011
- COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in CancerNucleic Acids Research, 2010
- Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urotheliumUrologic Oncology: Seminars and Original Investigations, 2010
- Phosphorylation of Akt (Ser473) is an Excellent Predictor of Poor Clinical Outcome in Prostate CancerCancer Research, 2004
- Clinical proteomics: translating benchside promise into bedside realityNature Reviews Drug Discovery, 2002
- Correlation between Protein and mRNA Abundance in YeastMolecular and Cellular Biology, 1999